Pharmacovigilance - E-BOOK, 2nd Edition
Key Features
- Presents vital, easy-to-read, cutting-edge information on patient safety, the pharmacology regulatory landscape, and the current and future use of digital technologies.
- Provides up-to-date coverage of hot topics in the field, including pharmacodynamic and safety precision medicine, immunogenicity, vaccine hesitancy and safety, genetic toxicology, and adverse events.
- Contains new chapters on pre-clinical safety assessment, pharmacogenetics, first-in human trials, product aggregate safety assessment, data monitoring committees, and more.
- Offers new and expanded coverage of pharmacovigilance in early pre-clinical drug development through post-marketing surveillance, as well as a blueprint for training future pharmacovigilance professionals.
- Includes real-world case studies to ensure content is relevant and applicable to everyday practice.
- Discusses a range of topics across disciplines and how they relate to pharmacovigilance, including behavioral science, patient perspectives, and risk communication.
- Any additional digital ancillary content may publish up to 6 weeks following the publication date.
Author Information
| ISBN Number | 9780443119309 |
|---|---|
| Main Author | Edited by Thao Doan, MD, Fabio Lievano, MD, PhD H.C., Linda Scarazzini, MD, Charles Schubert, MD, MPH and Barbara Hendrickson, MD |
| Copyright Year | 2026 |
| Edition Number | 2 |
| Format | eBook |
| Trim | 191w x 235h (7.50" x 9.25") |
| Imprint | Elsevier |
| Page Count | 0 |
| Publication Date | 20 Nov 2024 |
| Stock Status | IN STOCK |


eBooks : Built for busy schedules & tailored for your goals.


Affordable knowledge, built for you
Get the resources you need-often at a lower cost than print. Quality content designed to support your goals, without stretching your budget.


Seamless access wherever you are


Always in sync


Tools the make learning stick
Your eBook is ready whenever you are!
1. Check your email for your access code.


2. Sign into or create your VitalSource account and redeem your code.


3. Open your eBook - ready whenever you are!
FAQ
The access code for your new eBook will be sent in your order confirmation email. Your code can also be accessed in your My Account section on the Elsevier webshop. If you do not receive your code within a few minutes, please check your spam folder.
Step-by-step guidance on how to download Bookshelf and also redeem your code can be found here.
The access code for your new eBook does not expire. However, we always suggest redeeming immediately after purchase to start experiencing the benefits of and insights from your purchase. Important to note - the code provided is a single use code and only valid for the edition you purchase. It does not provide access to past nor future editions of the title.
You will have unlimited access to your eBook on the device to which it was downloaded.
Discover the various learning features that our eBooks offer on the Bookshelf® Reader! For example, you can highlight different text passages, create notes and flashcards, have the text read to you, etc. Particularly practical: You can also use your eBooks offline. More information on the learning functions can be found on the Vitalsource page.
Quality is our top priority. That's why we collaborate with the leading eBook reader provider VitalSource. VitalSource has its own eBook reader Bookshelf®, which you can easily download. This reader is very user-friendly and offers more features than other standard readers. For example, you can highlight different text passages, create notes and flashcards, have the text read to you, etc. Particularly practical: You can also use your eBooks offline. More information can be found on the Vitalsource page.
Elsevier offers its eBooks in ePub format, as we believe this format is best suited to display our content ideally on as many devices as possible.
You can return your eBook within 13 days of purchase. eBooks that have been partially printed or flipped through more than 15% are excluded from returns.
Any questions ?
Top Picks from Our Community
eBook
Edited by Catherine M. Otto
Feb 2026
eBook
eBook
Edited by Mariann M. Harding
Feb 2026
eBook
Edited by Lisa A. Lang
Feb 2026
eBook
Edited by Jasjit S. Suri
Sep 2021
eBook
Terry Des Jardins
Feb 2026
eBook
Edited by Micah K. Sinclair
Feb 2026
eBook
James Cox
Feb 2026
eBook
Joy V. Goldsmith
Jan 2026
eBook
Staci Nix
Jan 2026
eBook
Kathleen Deska Pagana
Jan 2026
eBook
Linda Lane Lilley
Jan 2026
eBook
Mariann M. Harding
Jan 2026
eBook
eBook
Edited by David A. Morrow
Jan 2026
eBook
Edited by Matthew D. Barber
Jan 2026
eBook
ASPAN and Pamela E. Windle
Jan 2026
eBook
J. M. Cairo
Aug 2016
eBook
Marilyn J. Hockenberry
Jan 2026
eBook
Elaine Beale
Jan 2026
eBook
Monica Breedlove
Jan 2026
eBook
Deborah E. Holmes
Jan 2026
eBook
Edited by Shawn D. St Peter
Jan 2026
eBook
Natalie Michaels
Jan 2026
eBook
Edited by Walter R. Frontera
Dec 2025
1. Does Regulation Drive Science or Does Science Drive Regulation?
SECTION 2 PRECLINICAL SAFETY ASSESSMENT
2. Absorption, Distribution, Metabolism and Excretion, Pharmacokinetics, and Safety Pharmacology
3. Preclinical Safety Assessment : General and Genetic Toxicology
4. Pharmacogenetics
SECTION 3 FIRST-IN-HUMAN TRIALS
5. Safety Planning for First-in-Human Trials
6. Pharmacokinetic and Pharmacodynamic Considerations in Safety Evaluation
SECTION 4 SAFETY ASSESSMENT IN CLINICAL TRIALS
7. Safety Monitoring in Clinical Trials
8. Introduction to Quantitative Methods and Visual Analytics in Drug Safety Data in Clinical Trials
9. Product Aggregate Safety Assessment
10. Data Monitoring Committees
SECTION 5 SIGNAL AND RISK MANAGEMENT
11. Methods of Signal Detection and Signal Management
12. Causality Assessment
13. Examples of Adverse Drug Reactions: Drug-Induced Liver Injury, Renal, Skin, Immune-Mediated Events, and Major Adverse Cardiac Events
14. Internal Safety Advisory Groups
15. Benefit–Risk Management
SECTION 6 ROLE OF EPIDEMIOLOGY AND REALWORLD EVIDENCE
16. Role of Epidemiology and Pharmacoepidemiology in the Biopharmaceutical Industry
17. Real-World Pharmacoepidemiology Studies
SECTION 7 SPECIAL POPULATIONS AND SPECIAL TOPICS
18. Pharmacovigilance in Pregnancy
19. Pharmacovigilance in Pediatrics
20. Pharmacovigilance in the Elderly
21. Vaccine Pharmacovigilance
22. Application of Human Factors and Health Literacy in Pharmacovigilance
23. Medical Device Safety Oversight and Surveillance
SECTION 8 THE NEXT FRONTIER
24. Information Technology in Pharmacovigilance: Current State and Future Directions
25. The Future of Pharmacovigilance